Iambic Therapeutics
The Associate Director, SEC Reporting and Technical Accounting leads external financial reporting in compliance with U.S. GAAP and SEC requirements while providing technical accounting leadership on complex transactions. This role oversees the design, implementation, and maintenance of the Company’s SOX program and serves as the primary liaison with external auditors. The position is based at the San Diego Headquarters in a hybrid work arrangement.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2020
Iambic Therapeutics is a biotech company applying an AI-driven platform — including its Enchant and NeuralPLexer technologies — to tackle the most challenging design problems in drug discovery and address unmet patient needs. Its high-throughput experimental platform converts novel molecular designs into biological insights, enabling faster development of potential best-in-class and first-in-class medicines. Iambic maintains a proprietary clinical pipeline targeting cancers such as HER2-driven tumors and breast cancer, and pursues collaborations with pharmaceutical partners, including Bayer, to advance AI-driven drug discovery.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Iambic Therapeutics.
8% below the average for this role
Director of SEC Reporting and Technical Accounting
Townsquare Media
Senior Manager, SEC Reporting
P.F. Chang's China Bistro, Inc.
External SEC Reporting Analyst
Corteva Agriscience
SEC Reporting Manager
Terrestrialenergy
SEC Reporting Manager
Taylor Morrison
Senior Manager, SEC Reporting & Technical Accounting
Gossamer Bio